Latest AI and machine learning research in breast cancer for healthcare professionals.
Chemoresistance and epithelial-mesenchymal transition (EMT) are associated with failure of cancer chemotherapy and poor survival of patients. We have previously shown that chemoresistance and stemness in hepatocellular carcinoma (HCC) cells was accompanied by the development of partial EMT (p-EMT) and identified a number of EMT-associated proteins that are released from exosomes. In this study, we...
Artificial intelligence (AI) is making notable advances in digital pathology but faces challenges in human interpretability. Here we introduce EXPAND (EXplainable Pathologist Aligned Nuclear Discriminator), the first pathologist-interpretable AI model to predict breast cancer tumor subtypes and patient survival. EXPAND focuses on a core set of 12 nuclear pathologist-interpretable features (NPIFs),...
Advancements in transmission electron microscopy (TEM) have enabled in-depth studies of biological specimens, offering new avenues to large-scale imag...
Accurate molecular subtyping of cancer is crucial for advancing personalized medicine. Although multiomics data contain valuable predictive informatio...
Identifying image features that associate strongly with diagnostic or prognostic classes in large-scale, multi-channel spatial imaging is challenging ...
Adoptive cell therapy with tumor-infiltrating lymphocytes (ACT-TILs) involves autologous TILs that are expanded ex vivo and then reinfused into the pa...
Esophageal-gastric cancers (EC) represent a significant global health concern, with esophageal cancer ranking seventh in terms of incidence and mortal...
Spaceflight presents unique environmental stressors, such as microgravity and radiation, that significantly affect biological systems at the molecular...
Recurrence related to poor prognosis is a leading cause of mortality in patients with breast cancer (BC). The MammaPrint (MP) genomic assay is designe...
Triple-negative breast cancer (TNBC) is an aggressive malignancy with limited targeted therapies and variable responses to conventional chemotherapy, ...
The tumor microenvironment (TME) significantly impacts cancer progression and overall patient survival. However, the complexity of tumor cell-TME inte...
Muscle-Invasive Bladder Cancer (MIBC) is a heterogeneous disease with distinct molecular subtypes influencing prognosis and therapeutic response. Howe...
Accurately estimating changes in binding free energy (ΔΔG) is essential for understanding protein-protein interactions (PPIs) and guiding rational pro...
Precision oncology aims to guide treatment decisions using biomarkers. While DNA-based panels are increasingly applied, RNA transcriptomics remain und...
Female genital tumors (FGTs), including ovarian, endometrial, and cervical cancers, pose a major global health challenge, yet their spatial and molecu...
Therapeutic antibody design is a complex multi-property optimization problem with substantial promise for improvement with the application of machine-...
Accurate breast cancer molecular subtyping is critical for treatment decisions, yet standard methods such as immunohistochemistry and gene expression ...
The three-dimensional organization of chromatin into topologically associating domains (TADs) may impact gene regulation by bringing distant genes int...
1. Microclimates are critical for understanding how organisms interact with their environments, influencing behaviour, physiology, and species distrib...
Controlled exit from and re-entry into the cell cycle is essential for multi-cellular life, while aberrant quiescent and senescent cell states have be...